Peter O. Hofgaard
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune cells in cancer
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Chemokine receptors and signaling
Papers in
- Immunology 13
- Immunotherapy and Immune Responses 12
- T-cell and B-cell Immunology 10
- Immune Cell Function and Interaction 6
- Oncology 8
- Chemokine receptors and signaling 3
- CAR-T cell therapy research 3
- Co-authors
- Bjarne Bogen (13 shared papers)Hilde Omholt (7 shared papers)Alexandre Corthay (4 shared papers)Katrin U. Lundin (4 shared papers)Egil Røsjø (1 shared paper)Guttorm Haraldsen (1 shared paper)Zlatko Dembić (4 shared papers)Ludvig A. Munthe (4 shared papers)
- Journals
- International Journal of Cancer (2 papers)Scandinavian Journal of Immunology (2 papers)Experimental Hematology (1 paper)European Journal of Immunology (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)
- Partner nations
- NorwaySwitzerlandJapan
In The Last Decade
Peter O. Hofgaard
19 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 84
- Immunology 718
- Oncology 476
- Hematology 153
- Molecular Biology 256
- Cancer Research 47
Countries citing papers authored by Peter O. Hofgaard
This map shows the geographic impact of Peter O. Hofgaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter O. Hofgaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter O. Hofgaard more than expected).
Fields of papers citing papers by Peter O. Hofgaard
This network shows the impact of papers produced by Peter O. Hofgaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter O. Hofgaard. The network helps show where Peter O. Hofgaard may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter O. Hofgaard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 356 | |
| 2 | 2014 | 157 | |
| 3 | 2015 | 84 | |
| 4 | 1995 | 75 | |
| 5 | 2003 | 64 | |
| 6 | 2012 | 58 | |
| 7 | 1998 | 53 | |
| 8 | 2009 | 45 | |
| 9 | 2003 | 35 | |
| 10 | 2011 | 35 | |
| 11 | 1994 | 31 | |
| 12 | 2004 | 22 | |
| 13 | 2008 | 17 | |
| 14 | 2017 | 13 | |
| 15 | 2023 | 8 | |
| 16 | 2004 | 3 | |
| 17 | 1998 | 3 | |
| 18 | 2023 | 2 | |
| 19 | 2015 | 1 |
About Peter O. Hofgaard
Peter O. Hofgaard is a scholar working on Immunology, Oncology, Hematology, Molecular Biology and Public Health, Environmental and Occupational Health, having authored 19 papers that have together received 1.1k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (12 papers), T-cell and B-cell Immunology (10 papers), Immune Cell Function and Interaction (6 papers), Chemokine receptors and signaling (3 papers), Multiple Myeloma Research and Treatments (3 papers), CAR-T cell therapy research (3 papers), Epigenetics and DNA Methylation (2 papers) and Vibrio bacteria research studies (1 paper). The work is most often cited by research in Immunology (718 citations), Oncology (476 citations), Hematology (153 citations), Molecular Biology (256 citations) and Cancer Research (47 citations). Peter O. Hofgaard has collaborated with scholars based in Norway, Switzerland and Japan. Frequent co-authors include Bjarne Bogen, Hilde Omholt, Alexandre Corthay, Katrin U. Lundin, Egil Røsjø, Guttorm Haraldsen, Zlatko Dembić, Ludvig A. Munthe, Kristina Berg Lorvik and Grete F. Lauritzsen. Their work appears in journals such as International Journal of Cancer, Scandinavian Journal of Immunology, Experimental Hematology, European Journal of Immunology and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.